Soleno Therapeutics (SLNO) Assets Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 214.62% |
| Dec 31, 2025 | 177.11% |
| Sep 30, 2025 | 165.71% |
| Jun 30, 2025 | 108.12% |
| Mar 31, 2025 | 95.54% |
| Dec 31, 2024 | 110.36% |
| Sep 30, 2024 | 91.03% |
| Jun 30, 2024 | 84.05% |
| Mar 31, 2024 | 43.86% |
| Dec 31, 2023 | 40.62% |
| Sep 30, 2023 | -3.98% |
| Jun 30, 2023 | -26.79% |
| Mar 31, 2023 | -15.27% |
| Dec 31, 2022 | -11.46% |
| Sep 30, 2022 | 3.64% |
| Jun 30, 2022 | 2.60% |
| Mar 31, 2022 | 3.06% |
| Dec 31, 2021 | -6.25% |
| Sep 30, 2021 | 11.34% |
| Jun 30, 2021 | 13.52% |
| Mar 31, 2021 | 16.00% |
| Dec 31, 2020 | 18.53% |
| Sep 30, 2020 | 39.61% |
| Jun 30, 2020 | 37.43% |
| Mar 31, 2020 | -1.76% |
| Dec 31, 2019 | 90.00% |
| Sep 30, 2019 | 51.21% |
| Jun 30, 2019 | 83.38% |
| Mar 31, 2019 | 60.56% |
| Dec 31, 2018 | 73.93% |
| Sep 30, 2018 | 61.74% |
| Jun 30, 2018 | 56.08% |
| Mar 31, 2018 | 53.39% |
| Dec 31, 2017 | 66.88% |
| Sep 30, 2017 | 149.63% |
| Dec 31, 2016 | 51.93% |